CV Sciences Buy Hold or Sell Recommendation

CVSI -- USA Stock  

USD 4.04  0.11  2.65%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding CV Sciences is 'Hold'. Macroaxis provides CV Sciences buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CVSI positions. The advice algorithm takes into account all of CV Sciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CVSI buy-and-hold prospective. Check also CV Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell CV SciencesBuy CV Sciences


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon CV Sciences has a risk adjusted performance of (0.05), jensen alpha of (0.50), total risk alpha of (1.08), sortino ratio of 0.0 and treynor ratio of (0.27)
We provide buy or sell recommendation to complement the latest expert consensus on CV Sciences. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at this moment. To make sure CV Sciences is not overpriced, please confirm all CV Sciences fundamentals including its Cash per Share, Total Asset and the relationship between Revenue and Cash Flow from Operations . Given that CV Sciences has Price to Earning of 54.89X, we suggest you validate CV Sciences market performance and probability of bankruptcy to make sure the company can sustain itself this quarter and beyond given your latest risk tolerance and investing horizon.

CV Sciences Trading Alerts and Improvement Suggestions

CV Sciences generates negative expected return over the last 30 days
CV Sciences has high historical volatility and very poor performance
The company reported previous year revenue of 55.08M. Net Loss for the year was (2K) with profit before overhead, payroll, taxes, and interest of 33.88M.

CV Sciences current analysts recommendations

Target Median Price8.50
Target Mean Price8.50
Recommendation Mean2.00
Target High Price9.00
Number Of Analyst Opinions2
Target Low Price8.00

CV Sciences Returns Distribution Density

Mean Return0.31Value At Risk5.18
Potential Upside5.31Standard Deviation3.34
 Return Density 

Institutional Investors

Security TypeSharesValue
Farmers Trust CoCommon Shares21.1 K86 K
Fny Investment Advisers LlcCommon Shares91.4 K540 K
Farmers Trust CoCommon Shares21.1 K125 K
Essex Investment Management Co LlcCommon Shares4.6 K27 K
Alpha Omega Wealth Management LlcCommon Shares1051000
Hilton Capital Management LlcCommon Shares75 K323 K
Farmers Trust CoCommon Shares21.1 K91 K

CV Sciences Greeks

Alpha over DOW
Beta against DOW=1.18
Overall volatility
Information ratio =0.14

CV Sciences Volatility Alert

CV Sciences exhibits very low volatility with skewness of 0.67 and kurtosis of 1.53. However, we advise investors to further study CV Sciences technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare CV Sciences to competition

CV Sciences Fundamental Vs Peers

FundamentalsCV SciencesPeer Average
Return On Equity(0.01)% (0.31)%
Return On Asset0.35% (0.14)%
Operating Margin0.37% (5.51)%
Current Valuation392.48M16.62B
Shares Outstanding98.66M571.82M
Shares Owned by Insiders10.47% 10.09%
Shares Owned by Institutions0.14% 39.21%
Price to Earning54.89X28.72X
Price to Book13.18X9.51X
Price to Sales7.41X11.42X
Gross Profit33.88M27.38B
Net Income(2K)570.98M
Cash and Equivalents13.64M2.7B
Cash per Share0.14X5.01X
Total Debt5.58M5.32B
Debt to Equity18.00% 48.70%
Current Ratio2.97X2.16X
Book Value Per Share0.31X1.93K
Cash Flow from Operations11.67M971.22M
Earnings Per Share(0.002)X3.12X
Number of Employees7818.84K
Market Capitalization408.44M19.03B
Total Asset25.77M29.47B
Retained Earnings(21.65M)9.33B
Working Capital12.83M1.48B
Current Asset15.84M9.34B
Current Liabilities3.01M7.9B
Z Score45.88.72
   Acquisition by Grasser Joerg of 250000 shares of CV Sciences subject to Rule 16b-3 [view details]